130 related articles for article (PubMed ID: 21251160)
1. SPA-1 controls the invasion and metastasis of human prostate cancer.
Shimizu Y; Hamazaki Y; Hattori M; Doi K; Terada N; Kobayashi T; Toda Y; Yamasaki T; Inoue T; Kajita Y; Maeno A; Kamba T; Mikami Y; Kamoto T; Yamada T; Kanno T; Yoshikawa K; Ogawa O; Minato N; Nakamura E
Cancer Sci; 2011 Apr; 102(4):828-36. PubMed ID: 21251160
[TBL] [Abstract][Full Text] [Related]
2. Amino-terminal enhancer of split gene AES encodes a tumor and metastasis suppressor of prostate cancer.
Okada Y; Sonoshita M; Kakizaki F; Aoyama N; Itatani Y; Uegaki M; Sakamoto H; Kobayashi T; Inoue T; Kamba T; Suzuki A; Ogawa O; Taketo MM
Cancer Sci; 2017 Apr; 108(4):744-752. PubMed ID: 28178391
[TBL] [Abstract][Full Text] [Related]
3. SIPA1 promotes invasion and migration in human oral squamous cell carcinoma by ITGB1 and MMP7.
Takahara T; Kasamatsu A; Yamatoji M; Iyoda M; Kasama H; Saito T; Takeuchi S; Endo-Sakamoto Y; Shiiba M; Tanzawa H; Uzawa K
Exp Cell Res; 2017 Mar; 352(2):357-363. PubMed ID: 28237246
[TBL] [Abstract][Full Text] [Related]
4. GABARAPL1 suppresses metastasis by counteracting PI3K/Akt pathway in prostate cancer.
Su W; Li S; Chen X; Yin L; Ma P; Ma Y; Su B
Oncotarget; 2017 Jan; 8(3):4449-4459. PubMed ID: 27966458
[TBL] [Abstract][Full Text] [Related]
5. Spa-1 (Sipa1) and Rap signaling in leukemia and cancer metastasis.
Minato N; Hattori M
Cancer Sci; 2009 Jan; 100(1):17-23. PubMed ID: 19037996
[TBL] [Abstract][Full Text] [Related]
6. RNA interference-directed knockdown of urokinase plasminogen activator and urokinase plasminogen activator receptor inhibits prostate cancer cell invasion, survival, and tumorigenicity in vivo.
Pulukuri SM; Gondi CS; Lakka SS; Jutla A; Estes N; Gujrati M; Rao JS
J Biol Chem; 2005 Oct; 280(43):36529-40. PubMed ID: 16127174
[TBL] [Abstract][Full Text] [Related]
7. Expression of signal-induced proliferation-associated gene 1 (SIPA1), a RapGTPase-activating protein, is increased in colorectal cancer and has diverse effects on functions of colorectal cancer cells.
Ji K; Ye L; Toms AM; Hargest R; Martin TA; Ruge F; Ji J; Jiang WG
Cancer Genomics Proteomics; 2012; 9(5):321-7. PubMed ID: 22990111
[TBL] [Abstract][Full Text] [Related]
8. Genomic analyses of the metastasis-derived prostate cancer cell lines LNCaP, VCaP, and PC3-AR.
Sienkiewicz K; Yang C; Paschal BM; Ratan A
Prostate; 2022 Mar; 82(4):442-451. PubMed ID: 34951700
[TBL] [Abstract][Full Text] [Related]
9. Sipa1 is a candidate for underlying the metastasis efficiency modifier locus Mtes1.
Park YG; Zhao X; Lesueur F; Lowy DR; Lancaster M; Pharoah P; Qian X; Hunter KW
Nat Genet; 2005 Oct; 37(10):1055-62. PubMed ID: 16142231
[TBL] [Abstract][Full Text] [Related]
10. Activation of Rap1 promotes prostate cancer metastasis.
Bailey CL; Kelly P; Casey PJ
Cancer Res; 2009 Jun; 69(12):4962-8. PubMed ID: 19470770
[TBL] [Abstract][Full Text] [Related]
11. Characterization of integrin subunits, cellular adhesion and tumorgenicity of four human prostate cell lines.
Witkowski CM; Rabinovitz I; Nagle RB; Affinito KS; Cress AE
J Cancer Res Clin Oncol; 1993; 119(11):637-44. PubMed ID: 7688749
[TBL] [Abstract][Full Text] [Related]
12. LNCaP progression model of human prostate cancer: androgen-independence and osseous metastasis.
Thalmann GN; Sikes RA; Wu TT; Degeorges A; Chang SM; Ozen M; Pathak S; Chung LW
Prostate; 2000 Jul; 44(2):91-103 Jul 1;44(2). PubMed ID: 10881018
[TBL] [Abstract][Full Text] [Related]
13. A metastatic and androgen-sensitive human prostate cancer model using intraprostatic inoculation of LNCaP cells in SCID mice.
Sato N; Gleave ME; Bruchovsky N; Rennie PS; Beraldi E; Sullivan LD
Cancer Res; 1997 Apr; 57(8):1584-9. PubMed ID: 9108464
[TBL] [Abstract][Full Text] [Related]
14. A novel experimental heme oxygenase-1-targeted therapy for hormone-refractory prostate cancer.
Alaoui-Jamali MA; Bismar TA; Gupta A; Szarek WA; Su J; Song W; Xu Y; Xu B; Liu G; Vlahakis JZ; Roman G; Jiao J; Schipper HM
Cancer Res; 2009 Oct; 69(20):8017-24. PubMed ID: 19808972
[TBL] [Abstract][Full Text] [Related]
15. An EP4 antagonist ONO-AE3-208 suppresses cell invasion, migration, and metastasis of prostate cancer.
Xu S; Zhang Z; Ogawa O; Yoshikawa T; Sakamoto H; Shibasaki N; Goto T; Wang L; Terada N
Cell Biochem Biophys; 2014 Sep; 70(1):521-7. PubMed ID: 24744183
[TBL] [Abstract][Full Text] [Related]
16. Androgen deprivation induces selective outgrowth of aggressive hormone-refractory prostate cancer clones expressing distinct cellular and molecular properties not present in parental androgen-dependent cancer cells.
Tso CL; McBride WH; Sun J; Patel B; Tsui KH; Paik SH; Gitlitz B; Caliliw R; van Ophoven A; Wu L; deKernion J; Belldegrun A
Cancer J; 2000; 6(4):220-33. PubMed ID: 11038142
[TBL] [Abstract][Full Text] [Related]
17. Establishing human prostate cancer cell xenografts in bone: induction of osteoblastic reaction by prostate-specific antigen-producing tumors in athymic and SCID/bg mice using LNCaP and lineage-derived metastatic sublines.
Wu TT; Sikes RA; Cui Q; Thalmann GN; Kao C; Murphy CF; Yang H; Zhau HE; Balian G; Chung LW
Int J Cancer; 1998 Sep; 77(6):887-94. PubMed ID: 9714059
[TBL] [Abstract][Full Text] [Related]
18. CXCR6-CXCL16 axis promotes prostate cancer by mediating cytoskeleton rearrangement via Ezrin activation and αvβ3 integrin clustering.
Singh R; Kapur N; Mir H; Singh N; Lillard JW; Singh S
Oncotarget; 2016 Feb; 7(6):7343-53. PubMed ID: 26799186
[TBL] [Abstract][Full Text] [Related]
19. The Diasporin Pathway: a tumor progression-related transcriptional network that predicts breast cancer survival.
Crawford NP; Walker RC; Lukes L; Officewala JS; Williams RW; Hunter KW
Clin Exp Metastasis; 2008; 25(4):357-69. PubMed ID: 18301994
[TBL] [Abstract][Full Text] [Related]
20. AF-6 controls integrin-mediated cell adhesion by regulating Rap1 activation through the specific recruitment of Rap1GTP and SPA-1.
Su L; Hattori M; Moriyama M; Murata N; Harazaki M; Kaibuchi K; Minato N
J Biol Chem; 2003 Apr; 278(17):15232-8. PubMed ID: 12590145
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
